MedTrace Logo

Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.

NCT06958016 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-05-28

No results posted yet for this study

Summary

The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.

Conditions

  • Chronic Coronary Syndrome

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Grigorios Giamouzis, PhD Medicine · University of Thessaly

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-12
Primary Completion
2026-01-11
Completion
2027-01-11

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06958016 on ClinicalTrials.gov